Kolexia
Heudel Pierre Etienne Oncologie médicale
Heudel Pierre Etienne
Oncologie médicale
Centre Léon-Bérard
Lyon, France
278 Activités
159 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Récidive tumorale locale Métastase tumorale Tumeurs de l'ovaire Sarcomes Carcinomes Tumeurs de l'endomètre Seconde tumeur primitive Tumeurs du cerveau

Collaborateurs

Voir plus
Tredan Olivier
Tredan Olivier
Centre Léon-Bérard, Lyon, France
Bachelot Thomas
Bachelot Thomas
Centre Léon-Bérard, Lyon, France
Blay Jean Yves
Blay Jean Yves
Centre Léon-Bérard, Lyon, France
Perol David
Perol David
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
B3TSI
64 collaboration(s)
Dernière en 2023
Novartis
17 collaboration(s)
Dernière en 2023
Lilly
11 collaboration(s)
Dernière en 2023
Zeste Research
10 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
Impact of artificial intelligence in transforming the doctor–cancer patient relationship
ESMO Real World Data and Digital Oncology   01 mars 2024
VICTORIA: A Multicentric, Randomized, Non Comparative, Open-label Phase I/II Evaluating AZD2014 (Dual Mammalian Target of Rapamycin Complex 1/2 (mTORC1/mTORC2) Inhibitor) in Combination With Anastrozole Versus Anastrozole Alone in the Treatment of Metastatic Hormone Receptor-positive Endometrial Adenocarcinoma
Essai Clinique (Centre Léon-Bérard)   12 février 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
Consore: A Powerful Federated Data Mining Tool Driving a French Research Network to Accelerate Cancer Research.
International journal of environmental research and public health   07 février 2024
Early morning immune checkpoint blockade and overall survival of patients with metastatic cancer: An In-depth chronotherapeutic study.
European journal of cancer (Oxford, England : 1990)   22 janvier 2024
ATALANTE: A Randomized, Double-blinded, Phase III Study of Atezolizumab Versus Placebo in Patients With Late Relapse of Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer Treated by Platinum-based Chemotherapy and Bevacizumab
Essai Clinique (Roche)   02 janvier 2024
From data strategy to implementation to advance cancer research and cancer care: A French comprehensive cancer center experience.
PLOS digital health   19 décembre 2023
Étude chronothérapeutique de la perfusion d’inhibiteurs de checkpoint chez des patients atteints de cancer métastatique
Médecine du Sommeil   01 décembre 2023
A qualitative study of teleconsultation practices among French oncologists in a post-COVID-19 period.
Digital health   28 novembre 2023